Grouping Immune-modulation With Cryoablation (LOGIC) for Breast Cancers

Clinical trial NCT05806385 · NOT_YET_RECRUITING

Trial details

NCT number: NCT05806385
Sponsor: Texas Tech University Health Sciences Center
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Triple Negative Breast Cancer

Start date: 2026-03-01
Primary completion: 2027-01-01
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.